Company HH Biotechnology Holdings Company Other OTC
Equities
HHBT
US40423K1007
Real Estate Development & Operations
Business Summary
Sales per Business
USD in Million | 2014 | Weight | 2015 | Weight | Delta |
---|---|---|---|---|---|
Rental Income & Management Fee
96.4
%
| 8 | 100.0 % | 8 | 96.4 % | -3.57% |
Consumer Product Sales
3.6
%
| - | - | 0 | 3.6 % | - |
Sales per region
USD in Million | 2014 | Weight | 2015 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 8 | 100.0 % | 8 | 100.0 % | +0.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 09/16/09 |
Li Rong Wang
DFI | Director of Finance/CFO | 61 | 09/16/09 |
Liang Zou
COO | Chief Operating Officer | 44 | - |
Shuang Li
SEC | Corporate Secretary | - | 09/16/09 |
Sasaki Koji
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 09/16/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,059,966 | 13,968,942 ( 99.35 %) | 0 | 99.35 % |
Company contact information
HH Biotechnology Holdings Co.
C Site, 25-26F President Building No. 69 Heping North Street
110003, Shenyang
+
http://www.greatchinaholdings.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+13.93% | 29.15B | |
-5.68% | 27.94B | |
+25.27% | 26.02B | |
+16.51% | 24.95B | |
+39.14% | 22.49B | |
+14.83% | 22.19B | |
-3.03% | 18.48B | |
+2.83% | 16.73B | |
+22.13% | 15.89B |